moisturizing and nourishing body moisturizers

1. INCI & CAS

INCI: Glycerin · CAS: 56-81-5

2. Role in the formula

The glycerin note covers its polyol-humectant role in washes, gels, and emulsions and gives a formulation guide level.

3. Typical use levels (formulation guide)

• For gels and serums, the recorded level is 3–8% in this reference.
• For creams, use 2–5%.
• The rinse-off use-level reference is 2–4% in this reference.

Add Glycerin to the water phase; no separate melt step is needed.

4. Regulatory sources & global compliance

• A CosIng listing for Glycerin provides ingredient information, not approval of a supplied grade or finished product.
• The finished-product provisions of Regulation (EC) No 1223/2009 require a safety assessment covering the complete formulation with Glycerin as part of the finished cosmetic's safety documentation.
• Review the documentation for the actual Glycerin grade and the filing requirements for the target market.

5. Safety & risk assessment

Treat the listed amount as cosmetic-development guidance; it makes no claim of drug or OTC authorization and the finished formula still needs patch and stability testing.

6. Stability & packaging

Use cool, sealed storage away from strong light for the bulk; take oxidation sensitivity into account when selecting the final pack; confirm stability and pack fit with the final formula.

7. Claims language (Do / Don’t)

• For cosmetic use, this entry records Glycerin in a direction centered on humectant function.

• The cosmetic listing provides no basis for therapeutic effects, curative outcomes, or unsupported certification statements.
• This guide to Glycerin does not establish whitening effects, acne treatment, antiperspirant performance, sunscreen protection, or hair growth.

1. INCI & CAS

INCI: Squalane · CAS: 111-01-3

2. Role in the formula

The guide uses plant-derived squalane, a stable hydrocarbon emollient, and does not specify mineral oil.

3. Typical use levels (formulation guide)

• 2–6% is listed for gel-creams as a formulation guide.
• For dry oils, use 10–30% as a formulation guide.
• Balms: 5–15%.

Add Squalane through the oil phase; no additional wax-processing shear step is called for.

4. Regulatory sources & global compliance

• A CosIng entry naming Squalane does not by itself approve the purchased grade or complete cosmetic.
• The finished-product provisions of Regulation (EC) No 1223/2009 require the final cosmetic with Squalane to undergo a safety assessment before the finished product is marketed.
• Review the supplier TDS for the received Squalane grade, together with the target market's current filing requirements.

5. Safety & risk assessment

Treat the listed amount as cosmetic-development guidance; it does not qualify a finished product as a drug or OTC product with patch response and finished-product stability still to be verified.

6. Stability & packaging

Protect the sealed bulk from heat, sun, and unnecessary exposure; review airless or pump options if oxidation presents a concern; confirm stability and pack fit with the final formula.

7. Claims language (Do / Don’t)

• The cosmetic concept for Squalane in this entry centers on a light-emollient role.

• The ingredient guidance does not establish therapeutic effects, curative outcomes, or unsupported certification statements.
• The cosmetic guidance for Squalane does not substantiate whitening, acne treatment, antiperspirant action, sunscreen use, or hair-growth outcomes.

1. INCI & CAS

INCI: Butyrospermum Parkii Butter · CAS: 91080-23-8

2. Role in the formula

For creams, balms, and hair creams, shea butter supplies the triglyceride-butter cushion role; unrefined color and aroma are not presumed.

3. Typical use levels (formulation guide)

• Creams: 2–8% in this reference.
• 10–25% is listed for balms and butters as a formulation guide.

Melt Butyrospermum Parkii Butter with the oil phase; keep shear during cooling to help prevent a grainy butter texture.

4. Regulatory sources & global compliance

• CosIng may identify Butyrospermum Parkii Butter as an ingredient, but its entry does not approve a material grade or finished formula.
• Regulation (EC) No 1223/2009 sets the requirement for a safety assessment of the finished cosmetic containing Butyrospermum Parkii Butter as part of the finished cosmetic's safety documentation.
• Check the supplier's technical information for the Butyrospermum Parkii Butter grade and confirm the relevant market filing list.

5. Safety & risk assessment

The guide records a level for cosmetic formulation purposes; the listed level does not itself confer drug or OTC status and the finished formula still needs patch and stability testing.

6. Stability & packaging

Protect sealed bulk from warmth and direct light; for oxidation-sensitive formulas, consider an airless or pump pack; confirm final stability and pack compatibility on a representative batch.

7. Claims language (Do / Don’t)

• The cosmetic concept for Butyrospermum Parkii Butter in this entry centers on shea cushion.

• The available ingredient details does not demonstrate therapeutic results, cure claims, or unverified certification claims.
• This reference for Butyrospermum Parkii Butter is not evidence for whitening, acne care as treatment, perspiration reduction, sun protection, or hair growth.